AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Method for Predicting Drug-Target Interactions and Uses for Drug Repositioning

Technology Benefits

• Existing medications used for new therapies do not need retesting to indicate safety, thus saving drug companies time and money• The TMFS method will be able to match drugs to their targets more efficiently• In a recent study, the TMFS method predicted drug-target associations with a 91% accuracy• The TMFS method discovered that mebendazole has the structural potential to inhibit VEGFR2• The TMFS method predicted that dimethyl celecoxib can bind cadherin-11. This was later confirmed with surface plasmon resonance.Stage of DevelopmentThe TMFS method has been used to profile 3671 FDA approved/experimental drugs against 2335 human protein targets. A number of drug-target associations that have potential new disease applications have been predicted.

Detailed Technology Description

Existing drugs have the potential to be repurposed for new therapies using a computational proteochemometric method called “train, match, fit, streamline” (TMFS). The present method takes advantage of the known structure of a drug molecule, and matches them to known structural targets of human proteins within a database to use as potential new therapies.

Country/Region

USA

For more information, please click Here